Dr. Shimon Amselem | Microgravity | Best Researcher Award
Chief Scientist at Microgravity, Space Pharma, Israel
Dr. Shimon Amselem is a highly accomplished pharmaceutical professional with a Ph.D. in Pharmacology from the School of Pharmacy at the Hebrew University of Jerusalem. He has over 25 years of experience in the pharmaceutical industry, holding key positions such as Chief Scientific Officer at Space Pharma, Chief Scientist at ADAMA Israel, and Formulation and CMC Leader at Live Kidney. Dr. Amselem is also the Chief Executive Officer and Founder of Nextar Chem Pharma Solutions Ltd., a contract manufacturing and outsourcing company for pharmaceutical and analytical services.
Professional Profiles:
Education:
Dr. Shimon Amselem holds a Ph.D. in Pharmacology from the School of Pharmacy, a Master’s in Pharmaceutical Sciences, and a B.Sc. in Chemistry, all from the Hebrew University of Jerusalem. He also completed a Post-doctoral Fellowship at the Walter Reed Army Institute of Research in Washington, DC.
Experience:
Dr. Shimon Amselem has over 25 years of experience in the pharmaceutical industry. He has held key positions such as Chief Scientific Officer at SpacePharma and Marval Pharma Ltd. He is currently involved in the development of lab-on-chips nanosatellites for microgravity research. Dr. Amselem has also founded Nextar ChemPharma Solutions Ltd., a contract manufacturing company. He has published extensively and holds numerous patents in pharmaceutical development. His expertise lies in drug discovery, formulation development, and drug delivery technologies.
Research Interest:
Dr. Shimon Amselem’s research interests include drug discovery, formulation development, and drug delivery technologies. He has a particular interest in developing innovative drug delivery systems, such as liposome-based products and lipid-based nanotechnologies. He is also involved in the development of implantable biodegradable polymers for slow release of biopharmaceuticals and the encapsulation of antigens and peptides. Additionally, Dr. Amselem is interested in pharmaceutical development for vaccines and adjuvants, as well as microencapsulation of drugs and biological agents in various forms.
Skills:
Dr. Shimon Amselem is a highly skilled pharmaceutical professional with expertise in formulation development, drug discovery, and drug delivery technologies. He has a strong background in leading pharmaceutical companies and academic institutions, with over 25 years of experience in the industry. Dr. Amselem’s research interests include the development of innovative drug delivery systems, such as liposome-based products and lipid-based nanotechnologies. He has also been involved in the development of implantable biodegradable polymers for slow release of biopharmaceuticals and the encapsulation of antigens and peptides. Dr. Amselem’s skills extend to regulatory affairs, research and development, collaboration and leadership, patents and publications, analytical techniques, biopharmaceutics, and quality control. He is a valuable asset to the pharmaceutical industry, bringing a wealth of knowledge and experience to his work.
Research Focus:
Dr. Shimon Amselem’s research focuses on drug discovery, formulation development, and drug delivery technologies. He is particularly interested in developing innovative drug delivery systems, including liposome-based products and lipid-based nanotechnologies. His research also involves the development of implantable biodegradable polymers for the slow release of biopharmaceuticals and the encapsulation of antigens and peptides. Dr. Amselem’s work aims to advance the field of pharmaceutical development by improving drug delivery efficiency and efficacy, ultimately leading to better treatment outcomes for patients.